Eurobio Scientific SA represents a values-driven corporate philosophy focused on innovation, excellence, and customer satisfaction. Committed to advanced molecular diagnostics, the company strives to provide cutting-edge solutions in the field of in-vitro diagnostics. Eurobio Scientific SA aims to bring value to its stakeholders through its diligent approach to research and development, using state-of-the-art technology and scientific expertise. By constantly improving products and services, Eurobio Scientific SA aims to enhance patient care while contributing to the advancement of scientific knowledge in diagnostics. With a strong emphasis on quality, reliability, and continuous improvement, Eurobio Scientific SA has established itself as a trusted and forward-thinking player in the industry.

Eurobio Scientific SA is primarily present in France and has a strong presence in Europe. The company is a leading player in the field of in vitro diagnostics with a wide range of molecular biology and immunology products. Eurobio Scientific SA has established a strong market position in France, where it has a significant customer base. Additionally, the company has expanded its reach across Europe, serving customers in various countries and regions. Eurobio Scientific SA's commitment to innovation and high-quality products has contributed to its success and recognition in the global healthcare industry.

Eurobio Scientific SA has achieved several significant milestones in its journey. The company has continually expanded its product portfolio, focusing on the development and commercialization of in-vitro diagnostics and innovative solutions for the medical field. Eurobio Scientific SA has successfully established strategic partnerships to strengthen its market presence and enhance its research capabilities. The company has also demonstrated continuous growth, with increasing revenues and expanding market reach. Through its consistent dedication to innovation and quality, Eurobio Scientific SA has positioned itself as a trusted leader in the field, delivering advanced diagnostic solutions to improve patient care and outcomes.

Eurobio Scientific SA is a renowned company with a rich history in the field of life sciences. Established years ago, Eurobio Scientific has emerged as a key player in providing high-quality products and services for clinical diagnostics. The company focuses on designing, manufacturing, and distributing an extensive range of in-vitro diagnostic (IVD) tests and reagents. Eurobio Scientific SA has gained a strong presence in the global market, with a diverse portfolio serving various medical fields such as infectious diseases, transplantation, and oncology. By consistently delivering innovative solutions and maintaining a commitment to excellence, Eurobio Scientific SA continues to contribute significantly to advancing healthcare worldwide.

The main competitors of Eurobio Scientific SA in the market are companies like bioMérieux, DiaSorin, and QIAGEN.

Eurobio Scientific SA is primarily active in the healthcare and life sciences industries.

The business model of Eurobio Scientific SA is focused on the development, manufacturing, and marketing of in-vitro diagnostic (IVD) tests. Eurobio Scientific SA specializes in providing innovative solutions for clinical diagnostics in the fields of infectious diseases, immunology, and cancer. The company's product portfolio includes a broad range of tests and reagents that are used by laboratories and healthcare professionals worldwide. Eurobio Scientific SA's business model combines research and development with efficient manufacturing processes to produce high-quality IVD products that cater to the evolving needs of the healthcare industry.

Коефициентът на цена спрямо печалбата (КЦП) на Eurobio Scientific е 33,76.

Коефициентът на цена към оборот (KUV) на Eurobio Scientific е 1,97.

AlleAktien качественият резултат за Eurobio Scientific е 3/10.

очаквана Eurobio Scientific оборотът е 142,14 млн. EUR.

очаквана Eurobio Scientific печалба е 8,29 млн. EUR.

Eurobio Scientific SA is a French company that specializes in the development, production, and marketing of in-vitro diagnostics. The company operates in three main business areas: health and life sciences, life sciences, and clinical diagnostics. Eurobio offers a wide range of high-quality reagents and instruments for researchers in the health and life sciences field. In the field of clinical diagnostics, the company offers a range of diagnostics for molecular diagnostics, microbiology, immunology, and infection diagnostics. Eurobio works closely with researchers, clinicians, and companies to ensure its products meet the highest standards. The company is proud to offer its customers the best product and service offerings and is constantly improving to meet their needs.

Eurobio Scientific разпределя дивидента от 0 EUR на плащания годишно.

Дивидентата за Eurobio Scientific в момента не може да бъде изчислена или компанията не разпределя дивиденти.

ISIN на Eurobio Scientific е FR0013240934.

WKN на Eurobio Scientific е A2DVTN.

Тикерът на Eurobio Scientific е ALERS.PA.

През последните 12 месеца Eurobio Scientific изплати дивиденда в размер на . Това съответства на дивидендна доходност от около . За следващите 12 месеца се очаква Eurobio Scientific да изплати дивиденда в размер на 0 EUR.

Дивидентната доходност на Eurobio Scientific в момента е .

Eurobio Scientific изплаща дивидент на тримесечие. Той се разпределя в месеците .

Eurobio Scientific платеше дивиденда всяка година през последните 0 години.

За идните 12 месеца се очакват дивиденти в размер на 0 EUR. Това съответства на дивидентна доходност от 0 %.

Eurobio Scientific се отнася за сектор 'Здраве'.

За да получите последното дивидентно плащане от Eurobio Scientific на 20.09.2024 г. в размер на 0 EUR, трябваше да притежавате акцията в портфейла си преди Ex-деня на 20.09.2024 г..

Последното дивидентно плащане беше извършено на 20.09.2024 г..

През година 2023 Eurobio Scientific изплати 0 EUR под формата на дивиденти.

Дивидентите от Eurobio Scientific се изплащат в EUR.